Relapse Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-05-29
Clinical Trial Update: Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia [Phase 2, Phase 3]
Clinical trial update on decitabine combined with mBU/CY preconditioning for relapse/refractory acute leukemia in Phase 2/Phase 3.